Article
March 11, 2024
The ISCB Fellows program is a prestigious recognition within the field of computational biology honoring those who have made outstanding contributions to the discipline. These distinguished scientists and professionals have demonstrated exceptional leadership, research, and service, advancing the frontiers of computational biology and bioinformatics.
Awards
News Release
Data Science and Biotechnology
Engelhardt Lab
AI
Big Data
Gladstone in the News
March 10, 2024
New York Times—Several new artificial intelligence-powered programs are setting their sights on the fundamentals of biology. They are not simply tidying up the information that biologists are collecting. They are making discoveries about how genes work and how cells develop. Gladstone Assistant Investigator Christina Theodoris shares her journey of creating the deep learning model GeneFormer.
Cardiovascular Disease
Theodoris Lab
AI
Big Data
Gladstone in the News
March 4, 2024
Science News—In some people with long COVID, powerful immune players called T cells seem to go out of whack. In some long COVID patients, T cells that recognize SARS-CoV-2 can become exhausted, Nadia Roan's team reported in Nature Immunology in January. And scientists know that tired-out T cells can have trouble wiping out infection.
Research (Publication)
COVID-19
Virology
Roan Lab
Article
March 1, 2024
The health and science publication STAT has selected a breakthrough discovery from Gladstone to be part of its annual STAT Madness competition, in which research institutes compete for the title of champion. The winner is deemed the most innovative research institution in the country.
Research (Publication)
Cancer
Genomic Immunology
Doudna Lab
CRISPR/Gene Editing
Video
February 15, 2024
Watch the scientific presentations from the 2024 Bay Area Cardiovascular Science Symposium
Cardiovascular Disease
Gladstone in the News
February 12, 2024
Fierce Biotech—A naturally occurring mutation in T cells that leads to lymphoma can be weaponized to make engineered T-cell therapies more effective against cancer, including melanoma, findings from a new study in mice suggest. The study’s co-leads, dermatologist Jaehyuk Choi and scientist Kole Roybal, have launched a new biotech company called Moonlight Bio to take their findings to the clinic.
Research (Publication)
Cancer
Genomic Immunology
Parker Institute for Cancer Immunotherapy
Roybal Lab
Genomics
Gladstone in the News
February 7, 2024
Nature—Cancer cells are the ultimate survivors, riddled with mutations that let them thrive when healthy cells would die. These same mutations can boost the ability of game-changing cell therapies to quash cancer, a study in mice shows. “Natural T-cell function isn’t good enough. We need to explore the extremes of T-cell function,” says Kole Roybal, co-author of the new paper.
Research (Publication)
Cancer
Genomic Immunology
Parker Institute for Cancer Immunotherapy
Roybal Lab
Genomics
Gladstone in the News
February 1, 2024
San Francisco Business Times—Gladstone Institutes is one of the premier training facilities in the Bay Area for training aspiring biotech researchers. Its president, Deepak Srivastava, says the the economic dip in the industry currently is presenting challenges, especially for postdoc fellow who used to be quickly scooped up into high-paying jobs in the sector, but have had more trouble finding work as funding for biotech startups dried up and layoffs abound. He says the industry needs to do more to seed this pipeline early through programs in high school and early college with people from more diverse backgrounds.
Diversity
Gladstone in the News
January 18, 2024
KCBS Radio—Diagnoses of autism spectrum disorder, or ASD, have been rising over the past decades, with one in 36 children identified with the condition in 2020 compared to one in 150 back in 2000, according to the US Centers for Disease Control and Prevention. Nevan Krogan, PhD, senior investigator at Gladstone Institutes and director of the Quantitative Biosciences Institute at UC San Francisco, shares new research on genetic changes that contribute to ASD.
Gladstone Experts
Research (Publication)
Neurological Disease
Krogan Lab
